Profile
ALUR ABT BSX-PA BSX SYK MDT
Company Name Allurion Technologies Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $8.64M $196.03B $175.45B $140.97B $138.31B $109.32B
Employees 0.50K 114.00K 45.00K 48.00K 52.00K 95.00K
CEO Dr. Shantanu K. Gaur M.D. Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
ALUR ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 3 2 3 3
Quant Rating Sell Neutral Sell Neutral Neutral
Trading
ALUR ABT BSX-PA BSX SYK MDT
Last Close $3.14 $113.02 $122.18 $95.65 $362.8 $85.25
High 52 $8.87 $120.98 $122.18 $95.95 $392.15 $92.27
Low 52 $0.28 $100.07 $122.18 $59.92 $307.75 $76.84
Price vs. 52 Week High -64.6 % -6.58 % 0 % -0.31 % -7.48 % -7.61 %
Price vs. 52 Week Low 1021.43 % 12.94 % 0 % 59.63 % 17.89 % 10.94 %
Total Return
ALUR ABT BSX-PA BSX SYK MDT
1 Month Return 808.56 % -0.32 % 0 % 6.15 % -3.15 % 3.36 %
3 Month Return 352.32 % -2.61 % 0 % 10.23 % 1.06 % -5.11 %
6 Month Return 214 % 9.77 % 0 % 22.6 % 10.42 % 10.6 %
9 Month Return 31.38 % 3.79 % 0 % 41.83 % 6.98 % 6.26 %
YTD Return 630.23 % -0.08 % 0 % 7.09 % 0.76 % 6.72 %
1 Year Return -15.14 % -0.79 % 0 % 59.58 % 15.95 % -2.48 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALUR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.46 % - - 0.89 % 3.27 %
Dividend Paid and Capex Coverage Ration (TTM) -49.45 % 1.45 % 2.95 % 2.95 % 2.09 % 1.35 %
Dividend Per Share (TTM) - 1.65 % - - 3.24 % 2.79 %
Payout Ratio (TTM) - 65.3 % 1.29 % 1.29 % 33.4 % 84.54 %
Growth
ALUR ABT BSX-PA BSX SYK MDT
Asset Growth 39.6 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth -18.19 % -9.7 % 14.01 % 14.01 % 13.12 % 3.12 %
Revenue Growth -16.73 % -8.12 % 12.29 % 12.29 % 11.11 % 3.64 %
Revenue 3 Year - 18.5 % 40.06 % 40.06 % 41.29 % 8.85 %
Revenue 5 Year - 32.8 % 37.78 % 37.78 % 48.53 % 7.41 %
Revenue 10 Year - 63.89 % 84.02 % 84.02 % 126.63 % 43.65 %
EBIT Growth -147.04 % -22.53 % 42.09 % 42.09 % 36.85 % -6.22 %
Net Income Growth -118.06 % -17.45 % 128.22 % 128.22 % 34.22 % -2.18 %
Net Income 3 Yeari Growth Per Share -4824456.21 % 30.18 % 1209.43 % 1209.43 % 95.8 % 3.26 %
Net Income 5 Yeari Growth Per Share -4824456.21 % 144.68 % -9.39 % -9.39 % -12.21 % -19.5 %
Net Income 10 Yeari Growth Per Share -4824456.21 % 98.34 % 1315.23 % 1315.23 % 213.78 % -9.48 %
Operating Income Growth -147.04 % -22.53 % 42.09 % 42.09 % 36.85 % -6.22 %
Operating Cash Flow Growth (CFG) -36.19 % -24.21 % 64.02 % 64.02 % 41.43 % 12.39 %
Operating 3 Year CFG -553901637.22 % -6.04 % 61.83 % 61.83 % 12.02 % 10.18 %
Operating 5 Year CFG -553901637.22 % 16.69 % 667.41 % 667.41 % 40.12 % -1.78 %
Operating 10 Year CFG -553901637.22 % 95.01 % 113.53 % 113.53 % 96.25 % 3.3 %
EPS Growth -65 % -16.24 % 140 % 140 % 33.87 % -2.12 %
EPS Diluted Growth -65 % -16.37 % 137.78 % 137.78 % 33.71 % -2.13 %
Book Value Per Share 25.35 % 6.36 % 9.41 % 9.41 % 11.49 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -1077079.34 % 20.39 % 22.66 % 22.66 % 40.57 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -1077079.34 % 28.04 % 110.05 % 110.05 % 56.21 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -1077079.34 % 36.91 % 172.19 % 172.19 % 104.97 % 94.93 %
Dividend Per Share Growth - 8.64 % -49.88 % -49.88 % 7.97 % 1.54 %
Dividend 3 Year Growth Per Share - 42.02 % -2.5 % -2.5 % 30.56 % 19.02 %
Dividend 5 Year Growth Per Share - 82.38 % - - 59.67 % 38.05 %
Dividend 10 Year Growth Per Share - 259.93 % - - 183.29 % 147.94 %
Debt Growth -29.69 % -10.4 % 2.26 % 2.26 % -0.41 % 6.91 %
Free Cash Flow Growth -35.15 % -35.17 % 86.32 % 86.32 % 54.03 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
ALUR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 72.32 % 54.7 % 67.3 % 67.3 % 62.47 % 62.65 %
Return on Assets TTM -48.84 % 7.76 % 4.7 % 4.7 % 8.19 % 4.76 %
Return on Equity TTM 36.54 % 14.74 % 8.91 % 8.91 % 18.49 % 8.64 %
Return on Capital Employed TTM -186.35 % 11.6 % 8.57 % 8.57 % 12.38 % 7.56 %
Net Income Per EBT TTM 101.58 % 85.08 % 81.24 % 81.24 % 85.68 % 83.18 %
EBT Per Ebit TTM 41.59 % 98.29 % 79.87 % 79.87 % 93.61 % 87.63 %
EBIT Per Revenue TTM -168.66 % 16.73 % 17.33 % 17.33 % 20.37 % 17.83 %
Cash Flow To Debt Ratio TTM -129.45 % 58.27 % 26.08 % 26.08 % 24.79 % 25.4 %
Receivables Turnover TTM 3.5 4.48 6.36 6.36 5.88 5.27
Payables Turnover TTM 0.93 4.63 5.74 5.74 6.17 5.19
Inventory Turnover TTM 2.11 2.74 1.89 1.89 1.56 2.25
Fixed Asset Turnover TTM 648.03 % 388.07 % 454.83 % 454.83 % 557.01 % 512.52 %
Asset Turnover TTM 68.55 % 55.43 % 41.78 % 41.78 % 50.13 % 36.65 %
Operating Cash Flow Per Share TTM -0.78 5.03 1.99 1.99 10.07 5.61
Free Cash Flow Per Share TTM -0.79 3.74 1.33 1.33 8.41 4.29
Cash Per Share TTM 44.71 % 449.02 % 169.89 % 169.89 % 1229.07 % 622.97 %
Operating Cash Flow Sales Ratio TTM -143.57 % 21.18 % 18.45 % 18.45 % 17.47 % 21.81 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.02 % 74.31 % 66.93 % 66.93 % 83.49 % 76.43 %
Cash Flow Coverage Ratios TTM -129.45 % 58.27 % 26.08 % 26.08 % 24.79 % 25.4 %
Price To Free Cash Flows Ratio TTM -0.17 30.22 72.71 71.74 43.15 19.88
Price To Operating Cash Flows Ratio TTM -4.09 22.46 48.63 47.98 36.02 15.19
Price Cash Flow Ratio TTM -4.09 22.46 48.63 47.98 36.02 15.19
Income Statement (TTM)
ALUR ABT BSX-PA BSX SYK MDT
Revenue $0.05B $40.11B $14.24B $14.24B $20.5B $32.36B
Gross Profit $0.04B $22.13B $9.9B $9.9B $13.1B $21.15B
Gross Profit Ratio 77.61% 55.18% 69.49% 69.49% 63.89% 65.34%
EBITDA $-0.07B $10.61B $3.45B $3.45B $4.93B $8.2B
Net Income $-0.08B $5.72B $1.59B $1.59B $3.17B $3.68B
EPS Diluted -2.31 3.27 1.07 1.07 8.25 2.76
Balance Sheet (MRQ)
ALUR ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $14.55B $8.96B $8.96B $11.26B $24.77B
Total Liabilities $0.14B $34.39B $15.61B $15.61B $21.32B $39.56B
Total Equity $-0.07B $38.83B $19.53B $19.53B $18.59B $50.42B
Total Investments $0B $1.18B $0.41B $0.41B $0.08B $8.34B
Total Debt $0.04B $15.87B $9.49B $9.49B $13B $26.05B
Total Assets $0.07B $73.21B $35.14B $35.14B $39.91B $89.98B
Cash Flow Statement (TTM)
ALUR ABT BSX-PA BSX SYK MDT
Net Income $-0.08B $5.72B $1.59B $1.59B $3.17B $3.68B
Inventory $-0B $-0.23B $-0.66B $-0.66B $-0.8B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-0.03B $-1.14B $-3.67B
Operating Cash Flow $-0.06B $7.26B $2.5B $2.5B $3.71B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.8B $-0.58B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 111
AEMD Aethlon Medical, Inc. 0.6391
AFIB Acutus Medical, Inc. 0.07
AHCO AdaptHealth Corp. 10.38
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 214.98
AMIX Autonomix Medical, Inc. Common Stock 2.62
ANIK Anika Therapeutics, Inc. 15.86
AORT Artivion, Inc. 29.91
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.5
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.27
AVNS Avanos Medical, Inc. 15.82
AXDX Accelerate Diagnostics, Inc. 1.08
AXGN AxoGen, Inc. 18.54
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
BBLG Bone Biologics Corporation 0.98
ETFs With Exposure to ALUR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 292.43
VXF Vanguard Extended Market Index Fund 0 194.37
IWC iShares Micro-Cap ETF 0.00051 127.585
JSML Janus Henderson Small Cap Growth Alpha ETF 0.01 66.97
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 48.17
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 48.16
VBINX Vanguard Balanced Index Fund Investor Shares 0 48.16
VTSAX Vanguard Total Stock Market Index Fund 0 140.41
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.27
VITSX Vanguard Total Stock Market Index Fund 0 140.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.28
VEMPX Vanguard Extended Market Index InstlPlus 0 358.5
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 263.43
Unlock